PolarityTE Announces the Addition of Clinical Development and Regulatory Affairs Executive Jessica Shen, MD, MS to Board of DirectorsBusiness Wire • 07/30/20
PolarityTE Announces Positive Top-Line Data from Interim Analysis of SkinTE™ Diabetic Foot Ulcer TrialBusiness Wire • 07/24/20
PolarityTE Announces Interim Data from Diabetic Foot Ulcer Trial will be Presented at Symposium on Advanced Wound Care to be Held July 24-26, 2020Business Wire • 07/20/20
PolarityTE's (PTE) CEO David Seaburg on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
PolarityTE, Inc.'s (PTE) Management on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20
PolarityTE's stock loses nearly half its value after public offering of stocks, warrantsMarket Watch • 02/12/20
PolarityTE, Inc. (PTE) Management on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
PolarityTE, Inc. (PTE) Management on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
PolarityTE Shares Rally On Positive Readout From Skin Graft Study In Diabetic Foot UlcersBenzinga • 06/10/19
PolarityTE, Inc. (PTE) CEO Denver Lough on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/10/19